Epinephrine Bitartrate, Lidocaine Hydrochloride Injection — FDA Drug Shortage

Current — Fresenius Kabi USA, LLC

The FDA lists a drug shortage record for Epinephrine Bitartrate, Lidocaine Hydrochloride Injection (injection) from Fresenius Kabi USA, LLC with status Current. The shortage was first posted on Oct 14, 2016. Reported reason: Demand increase for the drug

Shortage details

Status
Current
Company
Fresenius Kabi USA, LLC
Package NDC
63323-481-57
Dosage Form
Injection
Presentation
Xylocaine, Injection, .005 mg/1 mL; 5 mg/1 mL (NDC 63323-481-57)
Initial Posting
Oct 14, 2016

Reason

Demand increase for the drug

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.